Type 1 Diabetes
.gif){kind=logo}
Recently diagnosed with Type 1 Diabetes? Take action.
Learn more: teplizumab
Learn more: ClinicalTrials.gov
West Nile Virus
West Nile Virus Phase 2 clinical study.Learn more: ClinicalTrials.gov Learn more: MGAWN1
In the News...
See what others are writing about about MacroGenics. Learn moreCollaborators
Eli Lilly and Company
In October 2007, Eli Lilly and Company and MacroGenics announced that the two companies had entered into a global strategic alliance to develop and commercialize teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules for use in the treatment of autoimmune diseases. Learn More
NIAID/NIH
In October 2006, MacroGenics announced that it had been awarded over $62 million in grants and contracts by the National Institute for Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), over five years to develop a monoclonal antibody to West Nile virus (WNV) as well as antibodies targeting other infectious diseases. Learn More 